Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
89
days
Active targeting strategies for PROTAC delivery in cancer therapy: Advances, challenges, and future perspectives
Authors
Meihan Liu; Yaoshu Song; Kexin Luo; Yongsheng Zhao; Hongpan ZhangShow moreShow less
Affiliations
Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; North Sichuan Medical College, PR China; North Sichuan Medical College Innovation Centre for Science and Technology, PR China; Key Laboratory of Integrated Precision Diagnosis and Treatment for Solid Tumors, Sichuan Provincial Health CommissionShow moreShow less
48
days
PCSK9 in the liver metastatic niche: From cholesterol homeostasis to tumor microenvironment reprogramming
Authors
Ander Martin; Helena García García; Iratxe Bañares; Abdel-Majid Khatib; Iker BadiolaShow moreShow less
Affiliations
University of Bordeaux, Bordeaux Institute of Oncology (BRIC)-UMR1312, Bordeaux, France; Department of Cell Biology and Histology, University of the Basque Country, B° Sarriena sn, Leioa 48940, SpainShow moreShow less
62
days
Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer
Authors
Breanna R. Buhay; Jaeson D. Chin; Rachel Y. Han; Mark R. Wakefield; Yujiang FangShow moreShow less
Affiliations
Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, United States; Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, United States; Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO, 65212, United StatesShow moreShow less
211
days
Multiple roles of circRNAs in cervical cancer: From fundamental carcinogenic mechanisms to clinical application prospects
Authors
Miao Huo; Haitao Zhang; Yan Hua; Hong Qin; Wei WangShow moreShow less
Affiliations
Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Wuyi Road, Taiyuan, Shanxi Province 030001, ChinaShow moreShow less
22
days
Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy
Authors
Zhun You; Zihan Lin; Yu Zhang; Libin Xu; Wen ZhangShow moreShow less
Affiliations
The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Gastrointestinal Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of immunology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of Orthopedic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Beijing Key Laboratory of Cell and Gene Therapy for Digestive System Cancers, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaShow moreShow less
36
days
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential
Authors
Ruihan Cao; Qianqian Wei; Si-si Yan; Caifeng Gong; Lin-lin Bu; Qiuji WuShow moreShow less
Affiliations
School of Medicine, Wuhan University, Wuhan 430062, China; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Provincial Clinical Research Center for Cancer, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China; Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, Department of Oral & Maxillofacial - Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaShow moreShow less
FAQ
How long does CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 11 complete review records for CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. The fastest paper went from submission to acceptance in 22 days (Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy, received 2026-05-07, accepted 2026-05-29); the slowest took 240 days. The average is 100.6 days and the median is 89 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
